Welcome to the
Delaware Society for Clinical Oncology

Events

Upcoming events

No events available.

Past events

17 Jun 2021	Neuroendocrine Tumors
18 May 2021	It’s Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
10 May 2021	Management of Oligometastatic Disease
22 Apr 2021	Gut Microbiome and Environmental Colon Cancer - the missing link?
18 Mar 2021	Update in Hematologic Malignancies
16 Mar 2021	Managing Advanced Prostate Cancer in the COVID-19 Era: What Do Oncologists Need to Know?
25 Feb 2021	Practice Changing Update from GI ASCO 2021
28 Jan 2021	Best of San Antonio Breast Cancer Symposium 2020
23 Nov 2020	Best of ASTRO 2020
15 Oct 2020	Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
24 Jun 2020	Cutaneous Squamous Cell Carcinoma: Managing Advanced Disease in the Era of Immunotherapy
16 Apr 2020	"A Treatment Option for the Management of Patients with Unresectable or Metastatic Melanoma and Intermediate or Poor-Risk, Previously Untreated Advanced Renal Cell Carcinoma"
06 Feb 2020	2019 San Antonio Breast Cancer Symposium Review
04 Nov 2019	Radiation to convert the tumor into an in situ vaccine
24 Oct 2019	Clinical Overview of LUTATHERA® (lutetium Lu 177 dotatate)
10 Oct 2019	Mini symposium on Liver-Directed therapy with 90Y Microspheres
05 Sep 2019	Oligometastatic Prostate Cancer: Options and Evidence
19 Jun 2019	ASCO 2019: GI Oncology Review
11 Apr 2019	The Current and Future Role of PARP Inhibition in the Management of Ovarian Cancer
28 Feb 2019	2018 San Antonio Breast Cancer Symposium Review
31 Jan 2019	Venclexta in CLL and AML
08 Nov 2018	Orienteering on the Complex Treatment Landscape for EGFR Mutant NSCLC: Latest Evidence to Guide Clinical Decisions in Everyday Community Practice
24 Oct 2018	Molecular Tumor Boards: One Size Does Not Fit All
25 Sep 2018	Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy
06 Sep 2018	Best Practice for Inflammatory Breast Cancer (IBC)
24 Jul 2018	Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy
07 Jun 2018	Targeting Multiple Mechanisms of Cancer Immune Evasion
23 May 2018	Oncotype DX AR-V7 Nucleus Detect Program
10 May 2018	New Agent for Extended Adjuvant Therapy for HER2+ Breast Cancer Patients
26 Apr 2018	Categorizing the Molecular Heterogeneity of Acute Myeloid Leukemia
12 Apr 2018	New Treatments in Indolent Lymphomas
28 Mar 2018	Paving the Path to Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
01 Mar 2018	New Agents and Emerging Strategies in the Management of Early and Advanced Breast Cancer
01 Feb 2018	2017 San Antonio Breast Cancer Symposium Review
11 Jan 2018	From Biologics to Biosimilars in Oncology Practice: A New Source of Value
02 Nov 2017	Emerging Perspectives in Cancer Biomarkers
19 Oct 2017	CAR T Cell Therapies in Hematologic Malignancies
05 Oct 2017	Emerging Perspectives in Cancer Immunotherapy
21 Sep 2017	Beyond the Guidelines: Clinical Investigators Provide Perspectives on Biomarker-Guided Decision-Making for Patients with Non-Small Cell Lung Cancer
07 Sep 2017	Prostate Cancer Heterogeneity: Clinical Implications
08 Jun 2017	Recently Approved and Emerging Strategies in the Management of Gastrointestinal Cancers
18 May 2017	Pancreatic Cancer: New Horizons
27 Apr 2017	Why Novel Local Therapies are Essential for Systemic Cancer Cures
06 Apr 2017	Investigating the Potential of Immuno-Oncology Research
09 Mar 2017	The ACA: How Its Changing Health Care
12 Jan 2017	2016 San Antonio Breast Cancer Symposium Update
01 Dec 2016	Using Genomics to Improve Active Surveillance
10 Nov 2016	Uterine Leiomyosarcomas: Breaking the Code
13 Oct 2016	Locally Advanced and Metastatic Bladder Cancer Management
29 Sep 2016	Management of Multiple Myeloma in the Community Setting
01 Sep 2016	Integrating the 4th Modality: Immunotherapy for HNSCC
19 May 2016	The Molecular Basis of Cancer - Breast (MBOC)
05 May 2016	ASCO GI Highlights
21 Apr 2016	Targeting the Immune System to Improve Patient Outcomes in Advanced NSCLC
24 Mar 2016	Update on Precision Medicine: Identifying Opportunities and Overcoming Obstacles
25 Feb 2016	2015 San Antonio Breast Cancer Symposium Update
04 Feb 2016	Emerging Strategies in Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma
10 Dec 2015	NRG Oncology Update
12 Nov 2015	Topic - advances in RX for treating severe cancer pain
22 Oct 2015	Advances in Immune Therapy: Checkpoint Blockade and Radiotherapy
21 May 2015	Updates in Hematology 2015
23 Apr 2015	Can Understanding the Biology of Lymphoma Aid Patient Management?
16 Apr 2015	Multiple Myeloma- Biology, Evolution & Minimal Residual Disease
02 Apr 2015	The Molecular Basis of Cancer Immunotherapy
12 Mar 2015	Optimizing Radiotherapy for High Risk Prostate Cancer
12 Feb 2015	Oncology Exchange: Evolving Treatment Strategies for Mantle Cell Lymphoma in Elderly and Heavily Pretreated Patients
22 Jan 2015	2014 San Antonio Breast Cancer Symposium Update
13 Nov 2014	Clinical Trials Portfolio of the NCI Head and Neck Steering Committee
23 Oct 2014	Multiple Myeloma 2014
25 Sep 2014	Contemporary Issues in Soft Tissue Sarcoma
12 Jun 2014	Evidence-based Management of Metastatic Colorectal Cancer in the Community
22 May 2014	Emerging Genetic Tests for Localized Prostate Cancer: Ready for Prime Time?
13 May 2014	Genomic Tests for Breast Cancer: Fact, Myth & Everything in Between
08 May 2014	A Case Study Discussion of Multiple Myeloma Management
29 Apr 2014	Sarcoma Management Update
20 Mar 2014	2013 San Antonio Breast Cancer Symposium Update
27 Feb 2014	Cancer Genomic Profiling: What a Clinician Needs to Know
30 Jan 2014	Health Reform - Challenges of Implementation
12 Dec 2013	Expanding the Boundaries of Treatment of Patients with mCRC after Previous Therapies have Failed”
19 Nov 2013	Clinical Discussion of TAFLINAR (dabrafenib)
14 Nov 2013	Molecular Basis of Breast Cancer: Fundamental and Evolving Concepts
02 Oct 2013	Pancreatic Cancer Update 2013
12 Sep 2013	Multiple Myeloma Update 2013
05 Jun 2013	Considerations for the Development and Management of Clinical Pathways
16 May 2013	Molecular Biomarkers in Cancer
09 Apr 2013	New Approaces to the Management of DCIS
07 Mar 2013	Radiation Therapy in Non-Hodgkin Lymphoma: New Role, New Rules
17 Jan 2013	2012 San Antonio Breast Cancer Symposium Update
06 Dec 2012	"Gene Expression-Based Diagnostics for Molecular Cancer Classification of Difficult to Diagnose Tumors"
15 Nov 2012	Controversies in the Management of DCIS of the Breast
04 Oct 2012	Art of Active Listening: Delivering Emotional Charged News
20 Sep 2012	The Molecular Basis of Lung Cancer
31 May 2012	"The Value of FDG PET/CT Imaging in Oncology: Good, Better, Best Practice"
05 Apr 2012	"Advances in the Management of Colorectal Liver Metastasis"
07 Mar 2012	"Gastrointestinal Stromal Tumors (GISTs): Considerations for Surgeons" and "A Multidisciplinary Case Study on Gastrointestinal Stromal Tumors"
29 Feb 2012	Current Trends in the Adjuvant Treatment of Newly Diagnosed Node-Positive Melanoma
12 Jan 2012	2011 San Antonio Breast Cancer Symposium Update
03 Nov 2011	"Recent Advances in the Treatment of Metastatic Melanoma"
05 Oct 2011	"New Updates in the Treatment of Metastatic Prostate Cancer"
20 Sep 2011	"Case Studies in Metastatic Breast Cancer"
12 May 2011	Molecular Basis of Cancer
03 Mar 2011	"2010 San Antonio Breast Cancer Symposium Update"

Delaware Society for Clinical Oncology
c/o Megan Hayes
Medical Society of Delaware
900 Prides Crossing, Newark, Delaware 19713
Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org

This website brought to you by:

Terms and Conditions of Use

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds